Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours

被引:0
|
作者
Chmaj-Wierzchowska, K. [1 ]
Kampioni, M. [2 ]
Sajdak, S. [2 ]
Wilczak, M. [1 ]
机构
[1] Univ Med Sci, Dept Mothers & Childs Hlth, Poznan, Poland
[2] Univ Med Sci, Clin Surg Gynaecol, Poznan, Poland
关键词
Fibrinogen; CRP; hs-CRP; Ovarian tumours; C-REACTIVE PROTEIN; CANCER; ENDOMETRIOSIS;
D O I
10.12892/ejgo4175.2019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ovarian tumours can be classified as benign, borderline or malignant lesions. The purpose of this study was to assess, inter alia, fibrinogen concentration, and the (C-reactive proteins) and high-sensitivity CRPs (hs-CRPs) levels in the blood serum of patients with ovarian lesions. Study Design: The study involved patients treated laparoscopically and laparotomy in the Gynaecology and Obstetrics Clinical Hospital of the Poznan due to adnexal changes in the form of endometrial cysts and mature teratomas, mucinous cysts, borderline tumors of the ovary, simplex (serosa) cysts or haemorrhagic cysts. Results: The groups differed considerably in fibrinogen (p = 0.022) and d-dimer levels (p = 0.002). Conclusion: Statistically significant differences were found in the fibrinogen and d-dimer profiles among patients with benign and borderline ovarian tumours. However, this requires further investigations in larger patient groups.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [31] Higher Levels of hs-CRP Related to Corpus Callosum Volume in the Elderly
    Wynn, Matthew
    Dutt, Shubir
    Saloner, Rowan
    Kramer, Joel
    NEUROLOGY, 2016, 86
  • [32] Reduction in hs-CRP in coronary patients with exercise training and diet
    Milani, RV
    Lavie, CJ
    Brewer, G
    Mehra, MR
    CIRCULATION, 2001, 104 (17) : 414 - 414
  • [33] DINAMICS OF REDUSED GLUTATHIONE AND HS-CRP IN VASCULAR SURGICAL PATIENTS
    Mihajlovic, R.
    Jovanovic, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S319 - S319
  • [34] Plasma fibrinogen levels in patients with benign and malignant ovarian tumors
    Hefler-Frischmuth, Katrin
    Lafleur, Judith
    Hefler, Lukas
    Polterauer, Stephan
    Seebacher, Veronika
    Reinthaller, Alexander
    Grimm, Christoph
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 567 - 570
  • [35] FATIGUE IS ASSOCIATED WITH HS-CRP IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Aung, T.
    Sahakian, L.
    Skaggs, B.
    Grossman, J.
    McMahon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1238 - 1238
  • [36] Evaluation of endocan, CRP, hs-CRP levels in familial mediterranean fever patient with attack and attack free periods
    Kaplan, Mustafa
    Savuranoglu, Hasan Yasin
    Solmazgul, Emrullah
    Muftuoglu, Tuba
    Kara, Muammer
    Terekeci, Murat Hakan
    Onem, Yalcin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [37] High-sensitivity CRP (hs-CRP) level in children with nephrotic syndrome
    Wasilewska, A.
    Zoch-Zwierz, W.
    Tobolczyk, J.
    Tenderenda, E.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1594 - 1594
  • [39] Evaluation of HS-CRP and Lipid Profile in COPD
    Nillawar, Anup N.
    Joshi, Kedar B.
    Patil, Sandip Bharat
    Bardapurkar, Jayshree S.
    Bardapurkar, Suhas J.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (05) : 801 - 803
  • [40] hs-CRP as a predictive factor for cardiac outcome
    Wiwanitkit, Viroj
    ANNALS OF CARDIAC ANAESTHESIA, 2010, 13 (01) : 74 - 74